NCT03532347View on ClinicalTrials.gov

Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 22, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

November 4, 2018

Conditions
Pancreas CancerPancreas Neoplasm, BenignChronic PancreatitisPancreas Adenocarcinoma
Interventions
DEVICE

EUS-FNA needle (Beacon)

Participants will be randomised to an initial 3 passes with Beacon FNA and then Beacon SharkCore biopsy needles or vice versa. 25g needles will be used for trans duodenal puncture and 22g for trans gastric puncture.

Trial Locations (1)

NE7 7DN

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER